Did you get your copy of the
FenceBuilder Newsletter?

View the latest Fence Builder Newsletter

View all Past Issues here

Astrogliosis Occurs Selectively in Amygdala of Adolescent Primate and Rodent Following Daily Δ9-Tetrahydrocannabinol  

Among the advantages of this preclinical research is that there are no critical confounds (no family stress, no bad neighbourhoods, poor grades at school, no other drug use, dose and purity of THC are known, age of onset is fixed). Bear in mind: 13% of 12th graders in U.S. use marijuana daily. It's a complicated paper but here is the bottom line. In primate and rodent adolescent, daily THC caused:

  1.  An increase in inflammatory cells (GFAP-astrogliosis) in a key region of the brain, the amygdala. This brain region is implicated in a large array of physiological functions (survival, sizing up feelings, threats, safety,  generating anxiety fear, aggression, stress)  and psychopathology related to marijuana use (depression, anxiety, psychosis, hyperreaction to stress, sleep problems and others).
  2. This response to daily THC was observed only in adolescent amygdala, not in adult amygdala treated daily with THC!
  3. This response to daily THC was observed only in adolescent amygdala, and not in two other brain regions examined. 
  4. Other makers of inflammation were also elevated (complement factors). These are implicated in psychiatric disorders associated with adolescent cannabis exposure. Aberrant complement function has been linked to schizophrenia, depression, and anxiety, suggesting an overlapping contribution of this inflammatory pathway in cannabis associated psychiatric pathology.
  5.  THC-induced increases in these inflammatory markers may drive abnormal pruning in the amygdala to the detriment of establishing appropriate connections, dysregulating its behavioural outputs.
  6.  THC reduced two proteins that are critical for brain development and improve connections between nerve cells, but only in adolescent and not in adult amygdala. 
  7. Cannabidiol (CBD) prevented astrogliosis but did not restore proteins implicated in connectivity. 
  8. Increased inflammation correlated with fragmented sleep in primates. These changes may contribute to sleep disturbances observed in adolescent heavy marijuana users.  
  9. Reduced markers for connectivity correlated with anxiety Behavior in rodents
  10.  Same effects were found if specific brain cells (astrocytes) were isolated, cultured and exposed to THC. 
  11. Effects required cannabinoid receptors 
  12. THC reduced cannabinoid receptors in astrocytes in the adolescent brain, which may be the reason for these changes.  

In summary:  Results reveal that chronic THC exposure during a critical period of adolescent brain maturation elicited inflammatory activation of astrocytes and attenuated expression of certain proteins in the amygdala, together vital for regulation of sleep and anxiety. These mechanisms underscore the significant detrimental reorganization of the adolescent neuronal and glial landscape within the amygdala following chronic THC exposure, which does not occur in other brain regions or following comparable THC exposure in adult animals. Our results demonstrate a vital mechanism potentially underlying the increased risk of psychiatric disorders involving amygdala dysfunction following chronic cannabis use at a critical developmental stage.

(Click here for PDF Paper Source:  ScienceDirect)

Bertha K Madras, PhD

Professor of Psychobiology, Department of Psychiatry

Harvard Medical School

Featured Website

World Federation Against Drugs

World Federation Against Drugs (W.F.A.D) Dalgarno Institute is a member of this global initiative. For evidence based data on best practice drug policy in the global context.
Featured Website
Alt Tag

Institute for Behavior and Health

The Institute for Behavior and Health, Inc. is to reduce the use of illegal drugs. We work to achieve this mission by conducting research, promoting ideas that are affordable and scalable...
Featured Website

Drug Free Australia

Drug Free Australia Website. Drug Free Australia is a peak body, representing organizations and individuals who value the health and wellbeing of our nation...
Featured Website

Drug Advisory Council of Australia (D.A.C.A)

Drug Advisory Council of Australia (D.A.C.A) Dalgarno Institute is an executive member of this peak body. For updates on current illicit drug issues.
Featured Website

International Task Force on Strategic Drug Policy

(I.T.F.S.D.P) This international peak body continues to monitor and influence illicit drug policy on the international stage. Dalgarno Institute is a member organisation.
Featured Website

Smart Approaches to Marijuana

Smart Approaches to Marijuana. SAM's leaders are among the world's most prominent voices calling for science-based marijuana education and awareness.

21 Be There

There isn’t merely data sharing - it isn't about promoting a 'one dimensional' legislative solution to a complex problem
Featured Website

Drug Free Futures

Drug Policy Futures believes in engaging in an open dialogue about the strengths and weaknesses of global drug policies...
Featured Website

Action Alcohol

The National Alliance for Action on Alcohol is a national coalition of health and community organisations from across Australia that has been formed with the goal of reducing alcohol-related harm.
Featured Website

Greater Risk

Greater Risk Website - The younger they start the greater the risk...
Featured Website

Rivermend Health

RiverMend Health is a premier provider of scientifically driven, specialty behavioral health services to those suffering from alcohol and drug dependency, dual disorders, eating disorders, obesity and chronic pain.
Featured Website

Evidence-Based Practices Resource Center

SAMHSA is committed to improving prevention, treatment, and recovery support services for mental and substance use disorders.
Featured Website

SAMHSA

SAMHSA is committed to improving prevention, treatment, and recovery support services for mental and substance use disorders.